MedPath

A randomized controlled study to evaluate the efficacy of tamsulosin monotherapy and it combination with mirabegron on patients with overactive bladder induced by benign prostatic hyperplasia

Not Applicable
Conditions
Men with overactive bladder induced by benign prostatic hyperplasia
Registration Number
JPRN-UMIN000007269
Lead Sponsor
Department of Urologu, Sapporo Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with the real child plan 2. Patients suspected malignant disease 3. Patients with urinary retention 4. Ppatients with severe bladder diverticulum 5. Patients with urethral stricture 6. Patients with previous intrapelvic radiation 7. Patients with urinary tract infection, urinary stone, interstitial cystitis 8. Patients with performing clean intermittent catheterization 9. Patients with severe hepatic disorders, severe renal dysfunction and severe cardiovascular diseases 10.Patients who are judged as unsuitable for the trial by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath